Adipo Therapeutics is a biotechnology startup based in Indiana, founded in 2017. The company focuses on developing polymer-based, Notch-inhibiting nanoparticles aimed at inducing browning in adipose (fat) tissue, effectively transforming white fat cells into beige adipocytes. This innovative approach targets weight reduction and the restoration of metabolic balance, particularly beneficial for individuals with diabetes.
The recent investment of $1.90M in the form of a Convertible Note at 31 January 2024 came from a consortium of investors including Elevate Ventures, VisionTech Partners, IU Angel Network, and the Purdue Research Foundation. This funding is expected to bolster Adipo Therapeutics' research and development efforts, potentially propelling the company towards significant advancements in the biotechnology and healthcare sectors.
